Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
BACKGROUND: Treatment with daily aspirin for 5 years or longer reduces subsequent risk of colorectal cancer. Several lines of evidence suggest that aspirin might also reduce risk of other cancers, particularly of the gastrointestinal tract, but proof in man is lacking. We studied deaths due to cance...
Main Authors: | Rothwell, P, Fowkes, F, Belch, J, Ogawa, H, Warlow, C, Meade, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Effect of Daily Aspirin on Long-Term Risk of Death Due to Cancer: Analysis of Individual Patient Data From Randomized Trials
by: Rothwell, P, et al.
Published: (2011) -
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
by: Rothwell, P, et al.
Published: (2012) -
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
by: Rothwell, P, et al.
Published: (2012) -
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
by: Rothwell, P, et al.
Published: (2012) -
Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
by: Rothwell, P, et al.
Published: (2012)